

LONDON (Alliance News) - Silence Therapeutics PLC said Friday its compound for the treatment of iron overload disorders may "provide a safe, effective...


LONDON (Alliance News) - Silence Therapeutics PLC on Monday announced the departure of Chief Executive Ali Mortazavi with immediate effect after six y...


LONDON (Alliance News) - Silence Therapeutics PLC said Tuesday it has begun patent infringement proceedings in Portugal against Alnylam Pharmaceutical...


LONDON (Alliance News) - Silence Therapeutics PLC said Tuesday its full year loss narrowed after profitable share sales of its NASDAQ-listed peer Arro...


(ShareCast News) - Discoverer, deliverer and developer of novel RNA therapeutics for the treatment of serious diseases, Silence Therapeutics updated t...


(ShareCast News) - Silence Therapeutics, a developer of ribonucleic acid (RNA) treatments, has bought an 8.4% stake in Nasdaq-listed Arrowowhead Pharm...


(ShareCast News) - Silence Therapeutics said it has reached a settlement in the arbitration process with Quark Pharmaceuticals, with the former to rec...